Moderna concludes advanced talks with EU for Covid-19 vaccine supply
The potential agreement provides for an option for member states to buy an additional 80 million doses for a total of up to 160 million doses, the company said
A sign marks the headquarters of Moderna Inc, which is developing a vaccine against the coronavirus, in Cambridge, Massachusetts, US, May 18, 2020. Reuters/Brian Snyder/File Photo
Moderna Inc said on Monday it has concluded advanced exploratory talks with the European Commission to supply 80 million doses of its Covid-19 vaccine candidate.
The potential agreement provides for an option for member states to buy an additional 80 million doses for a total of up to 160 million doses, the company said.
